“Extremely impressive”: Geneva hospital wants to test mRNA vaccine against skin cancer

class=”sc-29f61514-0 jbwksb”>

“HUG is one of the centers that will likely be involved in a globally organized phase 3 study, along with three other locations in German-speaking Switzerland,” oncology professor Olivier Michielin said in an interview published in the “Le” newspaper. Temperatures».

If the vaccine is taken with the cancer drug Keytruda, it should provide a metastasis-free life for skin cancer patients. According to Michielin, the goal is to offer this combination to patients at high risk of relapse.

Michielin made the comments after the world’s largest annual cancer convention in Chicago. Results from manufacturer Moderna’s messenger RNA vaccine are presented here. They showed a significant reduction in relapses in combination with the cancer drug. The risk of re-metastasis in organs other than the skin is reduced by 65 percent. The oncologist said immunotherapy alone reduced the likelihood by 40 percent.

“We certainly didn’t expect to see numbers like this,” Michielin said. The excitement at the congress was at its peak. mRNA technology has revolutionized the field of cancer vaccination. Because there is the possibility of targeting many specific mutations with it.

Michielin said that this type of vaccine can also be used in transplants because of its low toxicity. That is, when immunotherapy is not possible. (SDA)

Source : Blick